Market Scope

The Irritable Bowel Syndrome Treatment Market Share should be securing a CAGR of 7.58% during the appraisal period (from 2020 to 2027). It is presumed that the irritable bowel syndrome treatment market will be worth over USD 2,900 Mn by 2027-end.

Renowned Contenders

The important IBS treatment solutions and devices manufacturers covered in the MRFR review study include Synergy Pharmaceuticals Inc., Ardelyx Inc., Astellas Pharma, Inc., Lexicon Pharmaceuticals, Inc., Abbott, Valeant Pharmaceuticals International, Inc., Ironwood Pharmaceuticals, Allergan Inc., Mallinckrodt, Nestle Health Science, and many more.

Get Sample Report: https://www.marketresearchfuture.com/reports/irritable-bowel-syndrome-treatment-market-7044

Market Segmentation

The major types of IBS are IBS-D, IBS-M., and IBS-C. Out of these, the IBS-D type is the top segment in the global market and will retain its dominance all through the upcoming period. It will be valued at USD 1790.6 Mn by 2027, while garnering a growth rate of 8.31% between 2020 and 2027.

The primary drug types available in the irritable bowel syndrome treatment industry include alosetron, linaclotide, lubiprostone, rifaximin, eluxadoline, and others.

Major industry end-users listed in the review study are research laboratories, clinics, hospitals, and others.

Top Boosters and Deterrents

The number of irritable bowel syndrome cases have surged at a dramatic pace across the globe over the past few years, fostering the market growth to a huge extent. Treatment of IBS/irritable bowel syndrome involves changes in diet, stress relief, counselling, and proper medicines. Medications that help treating irritable bowel syndrome are eluxadoline, rifaximin, linaclotide, lubiprostone, to name a few. Antispasmodics also find use as effective drugs for treating irritable bowel syndrome, which includes peppermint oil, hyoscyamine, and dicyclomine. The strong pipeline of these drugs developed by leading brands worldwide adds immensely to the worldwide market.

Rise in the diagnostics rate along with the surging government support bolster the business growth as well. Moreover, developments in biotechnological and pharmaceuticals sectors have been favorable for the global industry. Intense efforts by researchers to develop effective drugs for the treatment of IBS and the rise in funds granted by the authorities of respective regions in this regard can also benefit the worldwide market in subsequent years.

Renowned players are highly focused on new product launches, and are increasingly boosting their global presence by gaining entry into untapped markets. Various firms are coming together to form alliance, with the prime focus on conducting researches based on the treatment of acute pancreatitis. To cite an instance, in August 2021, Mahana Therapeutics, a leading digital therapeutics developer created a program that deals with the key symptoms associated with irritable bowel syndrome. The program has been developed on the basis of cognitive behavioral therapy, which is a technique that helps recognize and alter redundant thinking patterns as well as behaviors, which contribute to physical and mental health conditions.

Regional Analysis

Americas prevails as the global market leader, given the mounting awareness among people about IBS, blossoming patient base, and the well-established healthcare industry. As a result, the American market can achieve a strong valuation of USD 1,416.2 Mn by the end of 2027, clocking in a growth rate of 8.69% all through the assessment period. High availability of quality and superior healthcare facilities across the US and Canada and the rapidly burgeoning geriatric populace further fosters the market demand within the region. The sharp rise in the cases prompts a higher demand for highly effective diagnostic tests and treatment options in the region.

The extensive market growth in APAC is the result of the rising prevalence of irritable bowel syndrome and the soaring need for effective treatment methods. Considering the aggravating scenario in the region, a number of non-profit organizations and government agencies are taking up initiatives to boost the awareness level with regard to the disorder. Technological advances with respect to treatment have facilitated emergence of advanced solutions in the market, which could translate into substantial profits in the years to come. The soaring number of hospitals, and the escalating demand for affordable yet efficient treatments in India, Singapore, Vietnam, and China add significant value to the APAC market.

Browse Full Report: https://www.marketresearchfuture.com/reports/irritable-bowel-syndrome-treatment-market-7044

Related Report:

Periodontal Therapeutic Market Research Report – Forecast to 2027     

Smart Pills Market Research Report - Forecast to 2027  

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future®

99 Hudson Street,5Th Floor

New York, New York 10013

United States of America

Phone:

+1 628 258 0071(US)

+44 2035 002 764(UK)